PT Bundamedik Tbk (IDX: BMHS)

PT Bundamedik Tbk Income Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1,550,932	1,488,197	1,658,688	1,890,800	1,148,144	964,893
Revenue Growth (YoY)	-0.93%	-10.28%	-12.28%	64.68%	18.99%	13.22%
Cost of Revenue	841,355	813,590	915,848	942,939	679,913	519,838
Gross Profit	709,577	674,607	742,840	947,861	468,231	445,055
Selling, General & Admin	474,063	463,169	415,685	405,196	249,243	265,628
Other Operating Expenses	15,226	10,176	2,196	-3,721	-6,891	35,482
Operating Expenses	602,843	586,899	526,419	472,885	300,642	346,111
Operating Income	106,734	87,709	216,422	474,976	167,590	98,944
Interest Expense	-58,526	-53,290	-42,694	-20,031	-43,633	-56,148
Interest & Investment Income	11,101	8,424	8,363	10,178	4,734	2,041
Earnings From Equity Investments	-	-	-	-	25,816	4,545
Other Non Operating Income (Expenses)	-5,007	-4,473	-4,425	-7,984	-9,486	-2,245
EBT Excluding Unusual Items	54,301	38,369	177,665	457,139	145,020	47,137
Gain (Loss) on Sale of Assets	1,954	1,954	-874.84	-	-28.33	-23.19
Pretax Income	56,255	40,323	176,790	457,139	144,992	47,114
Income Tax Expense	27,619	24,094	47,858	102,490	26,532	15,797
Earnings From Continuing Operations	28,636	16,229	128,932	354,649	118,460	31,317
Minority Interest in Earnings	-14,471	-8,768	-45,704	-140,160	-29,669	-11,422
Net Income	14,165	7,461	83,228	214,489	88,791	19,895
Net Income to Common	14,165	7,461	83,228	214,489	88,791	19,895
Net Income Growth	-58.37%	-91.04%	-61.20%	141.57%	346.30%	287.97%
Shares Outstanding (Basic)	8,603	8,603	8,603	8,603	2,077	50
Shares Outstanding (Diluted)	8,603	8,603	8,603	8,603	2,077	50
Shares Change (YoY)	-	-	-	314.14%	4054.80%	-
EPS (Basic)	1.65	0.87	9.67	24.93	42.74	397.89
EPS (Diluted)	1.65	0.87	9.67	24.93	42.74	397.89
EPS Growth	-58.37%	-91.04%	-61.20%	-41.67%	-89.26%	287.97%
Free Cash Flow	-218,820	-157,915	-170,646	51,263	140,752	17,214
Free Cash Flow Per Share	-25.43	-18.35	-19.83	5.96	67.75	344.28
Dividend Per Share	-	-	1.500	2.557	-	-
Dividend Growth	-	-	-41.34%	-	-	-
Gross Margin	45.75%	45.33%	44.78%	50.13%	40.78%	46.12%
Operating Margin	6.88%	5.89%	13.05%	25.12%	14.60%	10.25%
Profit Margin	0.91%	0.50%	5.02%	11.34%	7.73%	2.06%
Free Cash Flow Margin	-14.11%	-10.61%	-10.29%	2.71%	12.26%	1.78%
EBITDA	208,614	182,468	306,066	537,580	223,186	150,920
EBITDA Margin	13.45%	12.26%	18.45%	28.43%	19.44%	15.64%
D&A For EBITDA	101,880	94,759	89,644	62,604	55,596	51,976
EBIT	106,734	87,709	216,422	474,976	167,590	98,944
EBIT Margin	6.88%	5.89%	13.05%	25.12%	14.60%	10.25%
Effective Tax Rate	49.10%	59.75%	27.07%	22.42%	18.30%	33.53%
Advertising Expenses	-	26,906	31,959	33,182	9,925	7,549

Source: S&P Capital IQ. Standard template. Financial Sources.